It has been reported that protein–protein interaction could abrogate the tumor-suppressive function of BRCA133, implying that the interaction of FOXP3 with some proteins may result in the loss of its tumor-suppressive properties in breast cancer. This evidence concerns the gene FOXP3 and breast carcinoma.